Stavnezer Appointed to NIH Allergy and Immunology Study Section

April 21, 2000

Janet M. Stavnezer, PhD, of Shrewsbury, professor of molecular genetics & microbiology and pathology at the University of Massachusetts Medical School, has been invited to serve on the Allergy and Immunology Study Section as part of the National Institutes of Health's Centers for Scientific Review. Appointed for three-year terms, section review members examine grant applications submitted to the NIH and make recommendations on them to the appropriate national advisory counsel or board. They also survey the status of research in their fields of science.

A molecular biologist, Dr. Stavnezer's research centers on immunogenetics ? the branch of immunology concerned with the interrelations of heredity, disease and the immune system. Her recent work has been supported by two NIH grants to study the molecular basis of antibody class switching, which occurs through the rearrangement of antibody genes. In particular, Stavnezer's laboratory is investigating the genetic activity that controls how certain immune system cells, called B cells, switch from producing one type of antibody to another.

Stavnezer came to UMMS in 1985 from the Cornell Medical School Graduate Division, where she was an assistant professor and researcher at the Sloan-Kettering Cancer Institute. She received her bachelor's degree with honors from Swarthmore College and her PhD from Johns Hopkins University. She also completed her postdoctoral training at John Hopkins as a National Institutes of Health (NIH) fellow.

Stavnezer trained at the University of California Medical School in San Francisco, where she was the Jane Coffin Childs Fellow, Dernham Fellow of the California Cancer Society, and special fellow of the Leukemia & Lymphoma Society This link goes to an external web site. She has authored or co-authored more than 70 articles for scientific journals and meetings including Science, International Immunology, the Journal of Experimental Medicine, the Journal of Biologic Chemistry, the Journal of Immunology and Cell.

The University of Massachusetts Medical School is one of the fastest growing academic health centers in the country, attracting more than $92 million in research funding annually. A perennial top ten finisher in the annual U.S. News & World Report ranking of primary care medical schools, UMMS comprises a medical school, graduate school of biomedical sciences, graduate school of nursing and an active research enterprise, and is a leader in health sciences education, research, clinical care and public service. In 1998, the UMMS system of hospitals and clinics merged with Memorial Health Care to form UMass Memorial Health Care, the clinical partner of the University of Massachusetts Medical School.